BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC). Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther 2019;49:1293-300. [PMID: 30908719 DOI: 10.1111/apt.15229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Simsek M, de Boer NKH. Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease-Authors' reply. Aliment Pharmacol Ther 2020;52:216-7. [PMID: 32529768 DOI: 10.1111/apt.15806] [Reference Citation Analysis]
2 Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC). Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther 2019;49:1293-300. [PMID: 30908719 DOI: 10.1111/apt.15229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Bayoumy AB, Mulder CJJ, Loganayagam A, Sanderson JD, Anderson S, Boekema PJ, Derijks LJJ, Ansari AR. Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine. Ther Drug Monit 2021;43:617-23. [PMID: 34521801 DOI: 10.1097/FTD.0000000000000869] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bayoumy AB, de Boer NKH, Ansari AR, Crouwel F, Mulder CJJ. Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective. J Pharm Policy Pract 2020;13:45. [PMID: 32695427 DOI: 10.1186/s40545-020-00249-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lansdorp CA, Buskens CJ, Gecse KB, D'Haens GRAM, van Hulst RA. Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2020;52:215-6. [PMID: 32529770 DOI: 10.1111/apt.15775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]